In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
After finishing at $52.24 in the prior trading day, Conmed Corp (NYSE: CNMD) closed at $52.08, down -0.31%. In other words, the price has decreased by -$0.31 from its previous closing price. On the day, 0.57 million shares were traded. CNMD stock price reached its highest trading level at $53.12 during the session, while it also had its lowest trading level at $51.82.
Ratios:
Our goal is to gain a better understanding of CNMD by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 45.42 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 9.79. For the most recent quarter (mrq), Quick Ratio is recorded 1.00 and its Current Ratio is at 2.26. In the meantime, Its Debt-to-Equity ratio is 0.91 whereas as Long-Term Debt/Eq ratio is at 0.91.
On April 28, 2025, Stifel Downgraded its rating to Hold which previously was Buy but kept the price unchanged to $55.
JP Morgan Downgraded its Overweight to Neutral on February 06, 2025, whereas the target price for the stock was revised from $85 to $70.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on May 05 ’25 when Farkas Charles sold 4,000 shares for $56.94 per share. The transaction valued at 227,768 led to the insider holds 16,346 shares of the business.
Farkas Charles bought 4,000 shares of CNMD for $227,768 on May 05 ’25. On Feb 14 ’25, another insider, Hartman Curt R, who serves as the Former Officer of the company, bought 2,905 shares for $64.89 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CNMD now has a Market Capitalization of 1611350016 and an Enterprise Value of 2468020224. As of this moment, Conmed’s Price-to-Earnings (P/E) ratio for their current fiscal year is 13.65, and their Forward P/E ratio for the next fiscal year is 11.04. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.64. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.23 while its Price-to-Book (P/B) ratio in mrq is 1.65. Its current Enterprise Value per Revenue stands at 1.875 whereas that against EBITDA is 11.058.
Stock Price History:
The Beta on a monthly basis for CNMD is 1.24, which has changed by -0.22465384 over the last 52 weeks, in comparison to a change of 0.092761636 over the same period for the S&P500. Over the past 52 weeks, CNMD has reached a high of $78.19, while it has fallen to a 52-week low of $46.00. The 50-Day Moving Average of the stock is -5.21%, while the 200-Day Moving Average is calculated to be -19.38%.
Shares Statistics:
The stock has traded on average 448.81K shares per day over the past 3-months and 387610 shares per day over the last 10 days, according to various share statistics. A total of 30.93M shares are outstanding, with a floating share count of 30.07M. Insiders hold about 2.81% of the company’s shares, while institutions hold 113.91% stake in the company. Shares short for CNMD as of 1748563200 were 2611253 with a Short Ratio of 5.82, compared to 1745971200 on 2429606. Therefore, it implies a Short% of Shares Outstanding of 2611253 and a Short% of Float of 11.53.
Dividends & Splits
In the trailing 12 months, CNMD’s forward annual dividend rate was 0.8, compared to 0.80 this year. Against a Trailing Annual Dividend Yield of 0.0153139355The stock’s 5-year Average Dividend Yield is 0.86. The current Payout Ratio is 18.82% for CNMD, which recently paid a dividend on 2025-06-13 with an ex-dividend date of 1749772800. Stock splits for the company last occurred on 2001-09-10 when the company split stock in a 3:2 ratio.
